Tachyon Receives IND Clearance from FDA to Develop Novel KDM4 Inhibitor TACH101
24 Aug 2022 //
BUSINESSWIRE
Tachyon and AbCellera Collaborate to Develop Novel Antibody Therapeutic
04 Aug 2021 //
BUSINESSWIRE
24 Aug 2022 //
BUSINESSWIRE
04 Aug 2021 //
BUSINESSWIRE